Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA pseudoephedrine website

This article was originally published in The Tan Sheet

Executive Summary

"Do I need a prescription from my doctor to buy pseudoephedrine?" and "What does 'behind-the-counter' mean?" are some of the questions answered by a new FDA 1webpage that provides consumers with information on the Combat Methamphetamine Epidemic Act of 2005. The page, posted on the Center for Drug Evaluation & Research website April 25, answers consumer questions such as, "I still see Sudafed PE on the shelves. Is this different from regular Sudafed?" and "Products containing pseudoephedrine are already considered prescription controlled substances in my state. Does this new law change that status?" The page directs consumers looking for further information to CDER's Division of Drug Information. The Meth Act was incorporated into the Patriot Act signed by the President in March; the law's behind-the-counter sales provision will take effect Sept. 30 ("2The Tan Sheet" March 13, 2006, In Brief)...

Related Content

Topics

UsernamePublicRestriction

Register

PS099326

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel